Fundz

MMS Holdings Appoints Ben Dudley as President

May 12, 2026

Position

President

Company

MMS

Ben Dudley
BiotechnologyData And AnalyticsHealth Care

Description

MMS Holdings has named Ben Dudley as President, building on his existing role as Chief Commercial Officer. This newly created position is aimed at supporting the company's growth as a science-led CRO.

Quick answer

MMS Holdings Appoints Ben Dudley as President (May 12, 2026).

Who is the new President at MMS?
MMS named Ben Dudley President, announced May 12, 2026.
What did MMS announce on May 12, 2026?
MMS Holdings has named Ben Dudley as President, building on his existing role as Chief Commercial Officer. This newly created position is aimed at supporting the company's growth as a science-led CRO.
What does MMS do?
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory...
Which similar companies made leadership changes around the same time?
Zephyr AI, Inc. (April 21, 2026), University of Bath (May 12, 2026), Infinitopes (May 12, 2026) and Zura Bio (May 13, 2026) also announced leadership changes within 45 days of MMS.

Source: Fundz verified event record.

Other recent leadership changes in Data And Analytics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MMS, and when

A new leader at MMS brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MMS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MMS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MMS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MMS

About

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MMS changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

James
Likely contact at this company
••••••••@••••••••

See James's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MMS's next move

Learn about Strategic plan

MMS changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.